BY OUR PLATFORMS
BY THERAPEUTIC AREA
ZeClinics expertise in CRISPR genome editing allows developing custom zebrafish genetic models to mimic human disease and addressing the biomedical relevance of candidate compounds and genes in vivo. Zebrafish bridges the gap between cell and rodent experimental models, enabling accelerated and cost-effective drug and target discovery.
“We have been working with ZeClinics for over a year now and we have been consistently satisfied with their services. Researchers from ZeClinics are detail-oriented, organized, and open to constructive feedback. They have always taken the time to discuss our new ideas or concerns and responded promptly to our questions, thus making our research effortless and pleasant.”
“I had a good experience with the ZeClinics team. It is an attentive and very responsive team.”
“ZeClinics has provided great service in the synthesis of a fish line within a short period of time. Detailed reports on the synthesis process were given to ensure that the right experimental supplies could be delivered for my scientific research. Aside from providing timely updates, ZeClinics provided clear and concise information so that I could rest assured that my delivery would arrive on-time. Staff providing the service are friendly and professional too especially in the worldly pandemic chaotic situation. Will definitely ask the service again in the near future.”
Department of Medicine, University of Hong Kong
CEO and Founder
“We’re very happy with ZeClinics services.”
Zebrafish Research Scientist
“In the discovery and development of new compounds for plant protection products, confirming the teratogenicity potential of the new compounds is very important. The teratogenicity study is conducted using rats or rabbits generally, it takes a high cost and long time. The developmental teratogenicity study using zebrafishes by ZeClinics provided us the data on teratogenicity potential with low cost and short time. The zebrafish study is very helpful for screening in the early stage of the discovery and development of new compounds.”
Virology and Ethnobotany Professor
“We had a wonderful experience with ZeClinics. We worked together on experimental plans and project proposals. They were proactive and inciteful in helping guide study designs to increase the chances of success. They compiled professional reports and timelines, never overpromised, and achieved all project deadlines. I greatly enjoyed working with them and had a lot of fun on our calls. I hope to work with them again.”
ZeClinics makes you part of our scientific team from the start of your project. Our scientific experts accompany you throughout the design, execution and reporting, so you will feel confident when you present the data to your stakeholders.
Zebrafish experimental advantages – number of individuals, small size, transparency – allow us to test the effect of several drugs and dosages in parallel: on specific tissues and the whole animal. Zebrafish shares high genomic and physiological conservation with humans, displaying analogous organs, cell types and biological processes. In short, the use of zebrafish will accelerate your research, while providing great translatability on how your candidate gene or molecule might impact human biology.
ZeClinics is focused on the zebrafish model because reducing the use of animals in experimentation is important for you, your company, society…and for us!
Full toxicology screening to obtain high quality data in a fast and cost-effective manner
FIND OUT MORE
Create your personalized genetic models through CRISPR/Cas9
Ready-to use disease models for multiple therapeutic areas & drug efficacy phenotypic screening
If you are involved in biomedical and chemical research you can benefit from ZeClinics expertise in zebrafish.
SCIENCE | 31 August 2023
We explore animal alternatives, particularly zebrafish larval models, along with advanced Crispr/Cas9 techniques, streamlining epilepsy modeling and antiepileptic drug trials.
NEWS | November 2023
The project combines ZeClinics' in vivo drug screening, Celtarys' fluorescent tools, and USC-Biofarma's in vitro screening expertise.
BLOG | Valentina Schiavone - 26 April 2023
BLOG | Miriam Martínez - 28 March 2023
Guarantee your research results with a reliable ethical alternative. We challenge traditional drug discovery by thinking differently. Let us help you carry out innovative research.
GET IN CONTACT